Zenotech Labs.
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Oct 23 (Reuters) - Zenotech Laboratories Ltd ZENL.BO:
ZENOTECH LABORATORIES - NAMES SACHIN LAXMANAPPA GAVANDARE AS CEO
Source text for Eikon: ID:nBSE6yHXgS
Further company coverage: ZENL.BO
(([email protected];))
Oct 23 (Reuters) - Zenotech Laboratories Ltd ZENL.BO:
ZENOTECH LABORATORIES - NAMES SACHIN LAXMANAPPA GAVANDARE AS CEO
Source text for Eikon: ID:nBSE6yHXgS
Further company coverage: ZENL.BO
(([email protected];))
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
- Business
- Financials
- Share Price
- Shareholdings
What does Zenotech Labs. do?
Zenotech Laboratories Ltd specializes in developing and manufacturing generic biopharmaceuticals to meet global medical needs. They offer services for generating and characterizing recombinant proteins, covering gene cloning to protein production.
Who are the competitors of Zenotech Labs.?
Zenotech Labs. major competitors are Jeevan Scientific, Vivo Bio Tech, Dishman Carbogen Amc, Sun Pharma Adv. Res, Syngene Internatl., Hikal, Suven Life Sciences. Market Cap of Zenotech Labs. is ₹287 Crs. While the median market cap of its peers are ₹3,027 Crs.
Is Zenotech Labs. financially stable compared to its competitors?
Zenotech Labs. seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
Does Zenotech Labs. pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Zenotech Labs. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Zenotech Labs. allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Accounts Receivable
How strong is Zenotech Labs. balance sheet?
Balance sheet of Zenotech Labs. is strong. It shouldn't have solvency or liquidity issues.
Is the profitablity of Zenotech Labs. improving?
No, profit is decreasing. The profit of Zenotech Labs. is -₹1.07 Crs for TTM, ₹5.61 Crs for Mar 2025 and ₹8.3 Crs for Mar 2024.
Is the debt of Zenotech Labs. increasing or decreasing?
Yes, The net debt of Zenotech Labs. is increasing. Latest net debt of Zenotech Labs. is -₹30.42 Crs as of Mar-26. This is greater than Mar-25 when it was -₹53.4 Crs.
Is Zenotech Labs. stock expensive?
Zenotech Labs. is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE. Latest PE of Zenotech Labs. is 0, while 3 year average PE is 46.78. Also latest EV/EBITDA of Zenotech Labs. is 27.49 while 3yr average is 21.41.
Has the share price of Zenotech Labs. grown faster than its competition?
Zenotech Labs. has given lower returns compared to its competitors. Zenotech Labs. has grown at ~2.47% over the last 8yrs while peers have grown at a median rate of 4.2%
Is the promoter bullish about Zenotech Labs.?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Zenotech Labs. is 68.84% and last quarter promoter holding is 68.84%.
Are mutual funds buying/selling Zenotech Labs.?
There is Insufficient data to gauge this.